(Q46291900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Robert Graham G Russell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Michael J. Rogers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Anke J Roelofs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Charlotte A Stewart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Shuting Sun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Boris A Kashemirov

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Charles E McKenna

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mark W Lundy

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Frank H Ebetino

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Fraser P Coxon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

Journal of Bone and Mineral Research

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

835-847

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22228189%20AND%20SRC:MED&resulttype=core&format=json

Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates

19 January 2020

cites work

1 reference

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs

21 January 2018

1 reference

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

21 January 2018

1 reference

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

21 January 2018

1 reference

The relationship between the chemistry and biological activity of the bisphosphonates.

21 January 2018

1 reference

Bisphosphonates: from the laboratory to the clinic and back again

21 January 2018

1 reference

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite

21 January 2018

1 reference

Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro

21 January 2018

1 reference

Differences between bisphosphonates in binding affinities for hydroxyapatite.

21 January 2018

1 reference

Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy

21 January 2018

1 reference

NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model

21 January 2018

1 reference

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

21 January 2018

1 reference

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.

21 January 2018

1 reference

Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo

21 January 2018

1 reference

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate

21 January 2018

1 reference

Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages.

21 January 2018

1 reference

Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.

21 January 2018

1 reference

Thermodynamics of bisphosphonates binding to human bone: a two-site model

21 January 2018

1 reference

Bisphosphonates: a review of their pharmacokinetic properties

21 January 2018

1 reference

Noninvasive optical detection of bone mineral

21 January 2018

1 reference

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

21 January 2018

1 reference

Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading.

21 January 2018

1 reference

Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs

21 January 2018

1 reference

A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice

21 January 2018

1 reference

Transduction of cell survival signals by connexin-43 hemichannels

21 January 2018

1 reference

Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo

21 January 2018

1 reference

Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate.

21 January 2018

1 reference

Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

21 January 2018

1 reference